Health Science Policy Council Chair 2023 - 2025
Maarten IJzerman, MSc, PhD
Dean and Professor Cancer Health Services Research, Erasmus School of Health Policy & Management
Rotterdam, Netherlands
Past Chair 2021-2023
Newell McElwee, PharmD, MSPH
Retired HEOR Professional
Gwynedd Valley, PA, United States
Chair-Elect 2025 - 2027
Deborah Marshall, PhD, BSc
Professor, Scientific Director Value and Impact, Alberta Children's Hospital Research Institute, University of Calgary
Calgary, AB, Canada
Health Science Policy Council Members
Policy Outlook Committee
Co-Chairs
Sita Ratna Devi Duddi
CEO, Dakshayani and Amaravati Health and Education
Gurugram, HR, India
Lou Garrison, PhD
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States
Members
Suliman Alghnam, MHA
Head, Population Health, KAIMRC
Riyadh, 01, Saudi Arabia
Eric Barrette
Senior Director, Health Economics, Medtronic
Washington, DC, United States
Amanda Cole, PhD, BSc
Associate Director, Office of Health Economics
London, LON, United Kingdom
Jessica Daw, MBA, PharmD
Vice President, Pharmacy, Sentara Health Plans
Virginia Beach, VA, United States
Eduardo Gonzalez-Pier, PhD
Distinguished Fellow, Center for Global Development
Cuidad de Mexico, Mexico
Jens Grueger, PhD
Director and Partner, Boston Consulting Group
Freiburg, BW, Germany
Jan E. Hansen, PhD, DrPH
Vice President, Evidence for Access, Genentech
South San Francisco, CA, United States
Isao Kamae, DrPH, MD
Project Professor, Health Policy and Technology Assessment, The University of Tokyo
Tokyo, 13, Japan
Finn Børlum Kristensen, PhD, MD
Danish Centre for Health Economics - University of Southern Denmark
Hilleroed, 84, Denmark
Newell McElwee, PharmD, MSPH
Retired HEOR Professional
Gwynedd Valley, PA, United States
Eberechukwu Onukwugha, MS, PhD, BA
Professor, University of Maryland, School of Pharmacy
Baltimore, MD, United States
Brian O'Rourke, PharmD
President, Brian O'Rourke Health Care Consulting Inc.
Ottawa, ON, Canada
Teodoro Padilla, MBA, BS
Executive Director, Pharmaceutical and Healthcare Association of the Philippines
Makati City, Philippines
Hemant Phatak, PhD
Amylyx Pharmaceuticals, Inc.
Needham, MA, United States
Laura Sawyer, MSc
Scientific Director, Symmetron
London, LON, United Kingdom
Adrian Towse, Mphil, MA
Emeritus Director, Office of Health Economics
London, United Kingdom
Martin Visnansky, MSc, MBA, PharmD, PhD
Senior Consultant / Lecturer, University of Veterinary Medicine and Human Pharmacy
Bratislava, BL, Slovakia
Science/Research Committee
Co-Chairs
Reed Johnson, PhD
Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States
Vivian Lee, PharmD, BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong
Members
J. Jaime Caro, MD
Chief Scientist, Evidera
Lincoln, MA, United States
Paolo Angelo Cortesi, PhD
Assistant Professor, Research Centre on Public Health (CESP), University of Milan-Bicocca
Monza, MB, Italy
William Crown, PhD, BA, MA
Distinguished Research scientist, Brandeis University
Waltham, MA, United States
Michael Drummond, PhD
Professor Emeritus, University of York
Lichfield, STS, United Kingdom
Stephanie Earnshaw, PhD
Senior Vice President, Health Economics, RTI Health Solutions
Pittsboro, NC, United States
Gihan Elsisi, MSc, PhD, MD, BSc
Ass prof, The American University in Cairo
cairo, C, Egypt
Daniel Erku, PhD, BSc
Research Fellow, Griffith University
Southport, QLD, Australia
Maarten IJzerman, MSc, PhD
Dean and Professor Cancer Health Services Research, Erasmus School of Health Policy & Management
Rotterdam, Netherlands
Zoltan Kalo, PhD
Professor of Health Economics, 1) Center for Health Technology Assessment, Semmelweis University; 2) Syreon Research Institute
Budapest, PE, Hungary
Shelby Reed, RPh, PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Diego Rosselli, MSc, MEd, BA, MD
Professor of Health Economics, Pontificia Universidad Javeriana
Bogota, CUN, Colombia
Ben van Hout, MSc, PhD
Chief Scientific Officer, OPEN Health
York, YOR, United Kingdom
Hwee-Lin Wee, PhD
Associate Professor, National University of Singapore
Singapore, Singapore
Task Force Review Committee
Co-Chairs
Joseph Cappelleri, MS, PhD, MPH
Executive Director, Pfizer Inc
Newington, CT, United States
Mark Sculpher, MSc, PhD, BA
Professor, University of York
York, NYK, United Kingdom
Members
Federico Augustovski, MSc, PhD, MD
Director, HTA, Institute for Clinical Effectiveness and Health Policy
Buenos Aires, B, Argentina
Marc Berger, MD
Principal, Marc L. Berger, LLC
New York, NY, United States
Daniel Malone, MS, RPh, PhD
Professor, University of Utah
Salt Lake City, UT, United States
Deborah Marshall, PhD, BSc
Professor, Scientific Director Value and Impact, Alberta Children's Hospital Research Institute, University of Calgary
Calgary, AB, Canada
C. Daniel Mullins, PhD
Professor, University of Maryland Baltimore
Baltimore, MD, United States
Scott Ramsey, PhD, MD
Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Lake Forest Park, WA, United States
Julia F. Slejko, PhD
Associate Professor, University of Maryland School of Pharmacy
Baltimore, MD, United States
Lotte Steuten, MSc, PhD
Deputy Chief Executive, Office of Health Economics
London, LON, United Kingdom
Praveen Thokala, PhD, MASc
Senior Research Fellow, ScHARR, The University of Sheffield
Sheffield, United Kingdom